CLXT News and Press, Calyxt Inc. From 06/22/21

Cellectis S.A. is an early clinical-stage immuno-oncology biotechnology company specializing in gene-edited T-cells that express chimeric antigen receptors for treating cancer. Cellectis offers a specialization in gene-editing, enabling their CAR-T product candidates to have addi...

Calyxt, Inc. (CLXT) Q1 2021 Earnings Conference Call May 06, 2021, 04:30 PM ET Company Participants Chris Tyson - EVP of MZ North America and IR, Calyxt Bill Koschak - CFO Yves Ribeill - Executive Chair of the Board Conference Call Participants Amit Dayal - Wainwright Bobby Burleson - Canacco...

The following slide deck was published by Calyxt, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Calyxt, Inc. 2021 Q1 - Results - Earnings Call Presentation

Early-Stage Validation that Next Generation Premium Soybean Product Performance is Best-in-Class for High Oleic, Ultra-Low Linolenic Profile Successful Transformation of Hemp Genome Enables Step Change in Calyxt's Innovation Approaches in the Species Promoted Sarah Reiter to the n...

Next Generation Premium Soybean Product Line Contains Ultra-Low Levels of Linolenic Acid Positioning it to be the Most Stable Premium Soybean Oil Available on the Market R&D Advancement with Complex Plant Biological Pathways Enables Calyxt to Deliver Next Generation Plant-Based Sol...

New Hemp Transformation Technology Unlocks Capabilities to Selectively Breed and Deliver Improvements in Hemp Traits for Key Markets Including Protein, Fiber, Advanced Materials and Wellness Patent-Pending Transformation Process is Calyxt's First Announced Innovation in a Broad Hemp Improvem...

If you've been watching the stock market lately, it might seem like investor interest in life-sciences businesses is as boundless as the technology they're producing. Enthusiasm for life-sciences stocks may be at an all-time high, but it's easy to lose your shirt when dealing with companies...

ROSEVILLE, MN / ACCESSWIRE / April 20, 2021 / Calyxt, Inc . (NASDAQ:CLXT), a plant-based technology company, will participate in the following investor and industry conferences during the month of May 2021: 2021 American Oil Chemists Society (AOCS) Annual Meeting & Expo Date: Ma...

Calyxt to Host First Quarter 2021 Financial Results Conference Call on Thursday, Ma y 6 , 202 1 at 4 :30 p .m. Eastern Time ROSEVILLE, MN / ACCESSWIRE / April 15, 2021 / Calyxt, Inc. (NASDAQ:CLXT), a plant-based technology company, will hold a conference call ...

Calyxt has changed its operating strategy to a more conventional agri-bio seed/trait model similar to those pursued by established agri-bio names like Bayer and Corteva. Calyxt is targeting new high-risk/high-reward market opportunities including winter oats, hemp, and soybeans with s...